179 related articles for article (PubMed ID: 8874437)
21. Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body.
Al-Jamal RT; Mäkitie T; Kivelä T
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2381-9. PubMed ID: 12766034
[TBL] [Abstract][Full Text] [Related]
22. Interval-by-interval Cox model analysis of 3680 cases of intraocular melanoma shows a decline in the prognostic value of size and cell type over time after tumor excision.
Gamel JW; McLean IW; Greenberg RA
Cancer; 1988 Feb; 61(3):574-9. PubMed ID: 3338025
[TBL] [Abstract][Full Text] [Related]
23. Cytomorphometry of uveal melanoma. Comparison of fine needle aspiration biopsy samples with histologic sections.
Char DH; Kroll SM; Stoloff A; Kaleta-Michaels S; Crawford JB; Miller TR; Howes EL; Ljung BM
Anal Quant Cytol Histol; 1991 Aug; 13(4):293-9. PubMed ID: 1718300
[TBL] [Abstract][Full Text] [Related]
24. Computerized histologic assessment of malignant potential: a method for determining the prognosis of uveal melanomas.
Gamel JW; McLean IW; Greenberg RA; Zimmerman LE; Lichtenstein SJ
Hum Pathol; 1982 Oct; 13(10):893-7. PubMed ID: 7129406
[TBL] [Abstract][Full Text] [Related]
25. Traumatic enucleation for posterior uveal melanoma.
Specht CS; McLean IW; Biscoe BW
Am J Ophthalmol; 1990 Nov; 110(5):518-21. PubMed ID: 2240138
[TBL] [Abstract][Full Text] [Related]
26. Uveal melanoma: the importance of large nucleoli in predicting patient outcome--an automated image analysis study.
McLean IW; Sibug ME; Becker RL; McCurdy JB
Cancer; 1997 Mar; 79(5):982-8. PubMed ID: 9041161
[TBL] [Abstract][Full Text] [Related]
27. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections.
Moshari A; McLean IW
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1160-3. PubMed ID: 11328722
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
29. Fine-needle aspirates of uveal melanomas and prognosis.
Folberg R; Augsburger JJ; Gamel JW; Shields JA; Lang WR
Am J Ophthalmol; 1985 Nov; 100(5):654-7. PubMed ID: 4061544
[TBL] [Abstract][Full Text] [Related]
30. Clinical Significance of Nucleoli Cytomorphology Assessment in Patients With Uveal Melanoma.
Berus T; Markiewicz A; Biecek P; Orłowska-Heitzman J; Hałoń A; Romanowska-Dixon B; Donizy P
Anticancer Res; 2020 Jun; 40(6):3505-3512. PubMed ID: 32487651
[TBL] [Abstract][Full Text] [Related]
31. A simple, efficient, and reproducible method for estimating the malignant potential of uveal melanoma from routine H & E slides.
McCurdy J; Gamel J; McLean I
Pathol Res Pract; 1991 Dec; 187(8):1025-7. PubMed ID: 1792184
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of the Callender classification of uveal melanoma cells.
Gamel JW; McLean IW
Arch Ophthalmol; 1977 Apr; 95(4):686-91. PubMed ID: 849191
[TBL] [Abstract][Full Text] [Related]
34. Metastatic uveal melanoma. Correlation between survival time and cytomorphometry of primary tumors.
Donoso LA; Augsburger JJ; Shields JA; Greenberg RA; Gamel J
Arch Ophthalmol; 1986 Jan; 104(1):76-8. PubMed ID: 3942548
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implications of cytopathologic classification of melanocytic uveal tumors evaluated by fine-needle aspiration biopsy.
Augsburger JJ; Corrêa ZM; Trichopoulos N
Arq Bras Oftalmol; 2013; 76(2):72-9. PubMed ID: 23828465
[TBL] [Abstract][Full Text] [Related]
36. Uveal melanoma prognostication: from lesion size and cell type to molecular class.
Gill HS; Char DH
Can J Ophthalmol; 2012 Jun; 47(3):246-53. PubMed ID: 22687301
[TBL] [Abstract][Full Text] [Related]
37. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.
Caujolle JP; Mammar H; Chamorey E; Pinon F; Herault J; Gastaud P
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):98-103. PubMed ID: 19910136
[TBL] [Abstract][Full Text] [Related]
38. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
39. Irradiated uveal melanomas: cytopathologic correlation with prognosis.
Char DH; Kroll SM; Miller T; Castro J; Quivey J
Am J Ophthalmol; 1996 Oct; 122(4):509-13. PubMed ID: 8862047
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive in vivo detection of prognostic indicators for high-risk uveal melanoma: ultrasound parameter imaging.
Coleman DJ; Silverman RH; Rondeau MJ; Boldt HC; Lloyd HO; Lizzi FL; Weingeist TA; Chen X; Vangveeravong S; Folberg R
Ophthalmology; 2004 Mar; 111(3):558-64. PubMed ID: 15019336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
